Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Photodynamic therapy of antifungal resistant dermatophytes
2020-002644-23Phase 2Terminated
- Sponsor
- Zealand University Hospital
- Start
- Jun 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, single-arm trial of methylene blue in dermatophytosis and tinea, sponsored by Zealand University Hospital. Primary endpoint: Clinical clearance of infection. Started Jun 2020; status: terminated.
02
Drugs
methylene blue
03
Conditions
dermatophytosistinea
Beyond the preview
Go deeper on 2020-002644-23.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2020-002644-23.